These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 3050211)

  • 1. [Influence of sodium intake on antihypertensive effect of calcium antagonist].
    Sakurai J
    Nihon Jinzo Gakkai Shi; 1988 Jun; 30(6):737-43. PubMed ID: 3050211
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of dietary sodium on the renin-angiotensin-aldosterone system and prevalence of left ventricular hypertrophy by EKG criteria.
    Williams JS; Williams GH; Jeunemaitre X; Hopkins PN; Conlin PR
    J Hum Hypertens; 2005 Feb; 19(2):133-8. PubMed ID: 15361890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sodium intake on the hypotensive effect of calcium antagonists.
    Sakurai J; Ikeda T; Toya Y; Gomi T; Ibukiyama C
    Jpn Heart J; 1989 Nov; 30(6):841-51. PubMed ID: 2632836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of nicardipine slow release (SR) on hypertension, potassium balance and plasma aldosterone in idiopathic aldosteronism.
    Veglio F; Pinna G; Bisbocci D; Rabbia F; Piras D; Chiandussi L
    J Hum Hypertens; 1990 Oct; 4(5):579-82. PubMed ID: 2283648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natriuretic and renal hemodynamic effects of nicardipine in essential hypertension.
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Kidney Int Suppl; 1988 Sep; 25():S184-6. PubMed ID: 3054236
    [No Abstract]   [Full Text] [Related]  

  • 6. Calcium antagonists in the treatment of hypertension: a critical overview.
    Weidmann P; Gerber A; Laederach K
    Adv Nephrol Necker Hosp; 1985; 14():197-232. PubMed ID: 3919532
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute response to calcium inhibitors in secondary arterial hypertension: does renin play a role?].
    Jeunemaitre X; Valenta de Almeida L; Sassano P; Farge D; Guyene TT; Julien J; Plouin PF; Corvol P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():141-4. PubMed ID: 3142397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of cardiovascular structural changes after long-term antihypertensive treatment with the calcium antagonist nitrendipine.
    Agabiti-Rosei E; Muiesan ML; Rizzoni D; Romanelli G; Beschi M; Castellano M
    J Cardiovasc Pharmacol; 1991; 18 Suppl 5():S5-9. PubMed ID: 1725798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicardipine did not activate renin-angiotensin-aldosterone system during isoflurane or sevoflurane anesthesia.
    Nishiyama T; Hanaoka K
    Can J Anaesth; 2000 Dec; 47(12):1249-52. PubMed ID: 11132749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of reduced sodium intake on blood pressure, body weight, renin, aldosterone, catecholamines, cholesterol and triglycerides. A meta-analysis].
    Graudal NA; Galløe AM; Garred P
    Ugeskr Laeger; 1999 Apr; 161(17):2526-30. PubMed ID: 10327874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Sodium outflow rate through lymphocyte cell membranes, serum levels of sodium, potassium, aldosterone, total catecholamines, 6-keto- PGF2alpha and plasma renin activity in patients with primary arterial hypertension treated with captopril].
    Mazurek W; Halawa B; Borejko-Słopecka G
    Pol Tyg Lek; 1992 Jul 6-13; 47(27-28):588-93. PubMed ID: 1488334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are the changes in urinary kallikrein excretion on altering sodium intake an index of salt sensitivity?
    Blackwood AM; Inoue J; Sagnella GA; Miller MA; Markandu ND; MacGregor GA
    J Hum Hypertens; 1994 Aug; 8(8):619-21. PubMed ID: 7990095
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihypertensive and humoral effects of verapamil and nifedipine in essential hypertension.
    Muiesan G; Agabiti-Rosei E; Castellano M; Alicandri CL; Corea L; Fariello R; Beschi M; Romanelli G
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S325-9. PubMed ID: 6184562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diurnal variation of blood pressure in salt-responder].
    Matsuoka H; Fukui K; Hayakawa H; Sugimoto T
    Nihon Rinsho; 1992 May; 50 Suppl():507-11. PubMed ID: 1387427
    [No Abstract]   [Full Text] [Related]  

  • 15. The effects of nicardipine on sodium and calcium metabolism in hypertensive patients: a chronic study.
    Soro S; Cocca A; Pasanisi F; Tommaselli A; de Simone G; Costantino G; Ferrara LA
    J Clin Pharmacol; 1990 Feb; 30(2):133-7. PubMed ID: 2179277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronobiologic evaluation of the efficacy of a new calcium antagonist, nicardipine hydrochloride, in 'essential hypertension'.
    Mukaiyama S; Ishii H; Komaya T; Tamura K
    Prog Clin Biol Res; 1990; 341A():369-75. PubMed ID: 2217254
    [No Abstract]   [Full Text] [Related]  

  • 17. Haemodynamic (systemic and renal) and humoral interactions between nicardipine and domperidone in hypertensives.
    Lucarini AR; Salvetti A
    J Hypertens Suppl; 1987 Dec; 5(5):S571-4. PubMed ID: 3327930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of salt intake on plasma calcitonin gene-related peptide in subjects with mild essential hypertension.
    Zoccali C; Mallamaci F; Parlongo S
    J Hypertens; 1994 Nov; 12(11):1249-53. PubMed ID: 7868872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. "Salt-sensitive" essential hypertension in men. Is the sodium ion alone important?
    Kurtz TW; Al-Bander HA; Morris RC
    N Engl J Med; 1987 Oct; 317(17):1043-8. PubMed ID: 3309653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicardipine in severe hypertension: oral therapy following intravenous treatment.
    Wallin JD; Bienvenu GS; Cook E; Laddu A; Turlapaty P; Clifton GG
    Int J Clin Pharmacol Ther Toxicol; 1990 Jan; 28(1):14-9. PubMed ID: 2303309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.